IP Library Assignment 032785/0012
Patent Assignment
Reel/Frame 032785/0012

Dissolution of Celltech R&D, Inc. and Subsequent Distribution of Assets into Darwin Molecular Corporation

Recorded: 2014-04-29 Pages: 8
Assignor
CELLTECH R&D, INC.
Executed: 2004-12-28
Assignee
DARWIN MOLECULAR CORPORATION
1950 LAKE PARK DRIVE, NE, SMYRNA, GEORGIA, 30080
Covered Properties (2)
Antibodies Specific for Sclerostin
Patent: 7,578,999 →
Application: 11/399,210 →
Publication: US 2006/0233801
Compositions and Methods for Increasing Bone Mineralization
Patent: 7,985,834 →
Application: 12/504,296 →
Publication: US 2010/0151524
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Nunc Pro Tunc Assignment Oct 25, 2013
From: DARWIN DISCOVERY LIMITED
To: UCB S.A.
Reel/Frame 031479/0219 →
Nunc Pro Tunc Assignment Oct 25, 2013
From: UCB S.A.
To: UCB PHARMA S.A.
Reel/Frame 031479/0358 →
Assignment of Assignor's Interest Apr 29, 2014
From: BRUNKOW, MARY E.; GALAS, DAVID J.; KOVACEVICH, BRIAN; MULLIGAN, JOHN T.
To: CELLTECH R&D, INC.
Reel/Frame 032781/0884 →
Assignment of Assignor's Interest Apr 29, 2014
From: SHI, JIYE; LATHAM, JOHN
To: CELLTECH R&D, INC.
Reel/Frame 032781/0929 →
Merger Apr 29, 2014
From: DARWIN MOLECULAR CORPORATION
To: UCB MANUFACTURING, INC.
Reel/Frame 032782/0091 →
Assignment of Assignor's Interest Aug 12, 2014
From: UCB MANUFACTURING, INC.
To: UCB PHARMA S.A.
Reel/Frame 033515/0904 →